Taoyuan, Taiwan, June 05, 2010 --(PR.com
)-- Min-Sheng General hospital in Taiwan will host the First Asian Diabetes Summit July16 and 17, 2010. The summit will look at the medical and surgical aspects of Incretin based Therapy. Bariatric surgery has recently been extended to metabolic surgery because of the associated gut hormone change and Incretin Effect.
Organized by Min-Sheng Hospital’s Bariatric & Diabetes Minimally invasive surgery center, the Diabetes Association of the Republic of China, and the Taiwan Association for Endoscopic Surgery, the summit is sponsored by the Taiwan Medical Association for the Study of Obesity, Taiwan Surgical Society of gastroenterology, and equipment maker Covidien. Speakers from across Asia and the United States will present the latest medical and surgical developments in the treatment of Diabetes Type II. Says Professor Lee Wei-Jei, Chairman of the organizing committee and Honorary President of the Asia Pacific Metabolic and Bariatric Surgery Society, “It is an appropriate time for gastro-intestinal metabolic surgeons in Asia to work with endocrinologists and all colleagues involved in the treatment of diabetes, to get together and share personal and institutional experience in the management of this disease.”
There will be a pre-congress live surgery workshop featuring Single Incision Laporoscopic Surgery (SILS) and Gastrointestinal Metabolic Surgery at Min-Sheng Hospital’s Minimally Invasive Surgery Center on Friday, July 16 with the main scientific congress taking place in the hospital’s auditorium Saturday, July 17. Min-Sheng General Hospital is a leading center for bariatric surgery in Asia, and received JCI CCP Certification (formerly known as DCSC) for its Diabetes Mellitus Type II Program in 2009.
Log on to www.apmbss.org/ADSS2010 or www.missioncare.com.tw for more information, or if you’d like to register to attend this event.
William Hoyois, Business development specialist
Min-Sheng general Hospital
Phone: 886 3 3179599 ext. 2080